Pietrantonio F1,2, Di Nicolantonio F3,4, Schrock AB5, Lee J6, Morano F1, Fuca G1, Nikolinakos P7, Drilon A8, Hechtman JF9, Christiansen J10, Gowen K5, Frampton GM5,…
Nassar AH1, Hamieh L2, Gray KP3, Thorner AR4, Fay AP5, Lasseter KD1, Abou Alaiwi S2, Nuzzo PV2, Flippot R2, Krajewski KM6, Signoretti S7, Choueiri TK2, Kwiatkowski DJ8. https://www.ncbi.nlm.nih.gov/pubmed/31653662
Shah CP1, Mramba LK2, Bishnoi R1, Unnikrishnan A3, Duff JM1,4, Chandana SR5,6,7. https://www.ncbi.nlm.nih.gov/pubmed/31602324
-“IMFINZI is first immunotherapy to show both significant survival benefit and improved, durable responses in extensive-stage small cell lung cancer”, presented at WCLC plenary…
Zhao W, Liu Y, Jenkins BD, Cheng R, Harris BN, Zhang W, Xie J, Murrow JR, Hodgson J, Egan M, Bankey A, Nikolinakos PG, Ali…
Weiss JM1, Csoszi T2, Maglakelidze M3, Hoyer RJ4, Beck JT5, Gomez MD6, Lowczak A7, Aljumaily R8, Lima CMR9, Boccia RV10, Hanna W11, Nikolinakos P12, Chiu…
Yardley DA1, Hart L2, Favret A3, Blau S4, Diab S5, Richards D6, Sparano J7, Beck JT8, Richards P9, Ward P10, Ramaswamy B11, Tsai M12, Blackwell…
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer:…
Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor–Positive, HER2-Negative Advanced Breast Cancer https://jamanetwork.com/journals/jamaoncology/fullarticle/2683625
Comprehensive statistical inference of the clonal structure of cancer from multiple biopsies. Liu J, Halloran JT, Bilmes JA, Daza RM, Lee C, Mahen EM, Prunkard…